C. Light is a #healthtech startup that aims to create digital solutions using the #retina as proxy for brain health. We are your trusted leader in #oculometrics
We are proud to partner with @SKERIResearch for the 2023 #FVAconference where our CEO Christy Sheehy-Bensinger, PhD will speaking on how quantitative measurements of fixational eye movements emerged as a valuable tool to potentially be used as a future #biomarker for #disease!
🚨⏳One week to the #FVAconference on Functional Vision and Accessibility at #SKERI! Contemplating last-minute/online registration? Check out this brief recap 🧵 of the program starting with Day 1 sessions👇🏼, or visit the site for details:
https://t.co/0XnkxvSpSW
#foundersfriday Meet the brains behind the eye-brain connection, Joe (CTO) and Christy (CEO)! An absolute dynamic force changing the face of healthcare as we know it 🤩 #retina#ai
"We’re heavily focused on AI technology…how can we make the algorithm technologies as generalizable as possible?" - Dr. Joe Xing from @CLightTech walks us through his thought process involving #AI and moving into 2023. #tech#futureoftech
New drugs are on their way for MS patients. Options are almost always a good thing, but only if we have enough information to make the best choice. Effective selection of these drugs will be critical for the best patient outcomes!
https://t.co/1dmnueswl0
It’s MS Awareness Week! Each day, people living with MS do whatever it takes to move their lives forward despite the challenges of #MS. Read and watch inspiring stories at https://t.co/leZoXTjYke and share to show the world #ThisIsMS.
What does it take to diagnose a concussion in the NFL? 13 physicians and trainers assessing subjective attributes about a player. And even this is far from definitive. Interesting read! #neurodiagnostics
https://t.co/ic5JbiBFF9
Excited to be part of the startup pitch competition at this year's 11th Annual Haas Healthcare Conference! Please join for a great day focused on tackling the biggest problems in healthcare at https://t.co/6QEwOIdsq0 are available here: https://t.co/y3R4PTnk87 @HaasHealthcare
New therapeutic strategies for MS are being developed every day. Assessment of impact should be an immediate piece of information all patients and physicians have access to. And we can do it through eye motion! #neurodiagnostics@MSNewsToday https://t.co/S22g7UZB2X